Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

Enzyme Inhibitor ◽

Converting Enzyme ◽

Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension

Journal of Hypertension ◽

10.1097/00004872-199511000-00017 ◽

1995 ◽

Vol 13 (11) ◽

pp. 1343-1351 ◽

Cited By ~ 63

Author(s):

Ilkka Tikkanen ◽

Per Omvik ◽

Henrik E.

Keyword(s):

Essential Hypertension ◽

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Beneficial effect of replacing of angiotensin-converting enzyme inhibitor with angiotensin II antagonist for heart failure patients

Journal of Clinical Pharmacy and Therapeutics ◽

10.1046/j.1365-2710.2002.00420.x ◽

2002 ◽

Vol 27 (4) ◽

pp. 267-271

Author(s):

Y. Hara ◽

M. Hamada ◽

Y. Shigematsu ◽

T. Ohtsuka ◽

K. Hiwada

Keyword(s):

Heart Failure ◽

Angiotensin Ii ◽

Beneficial Effect ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Heart Failure Patients ◽

Effects of angiotensin converting enzyme inhibitor cilazapril and angiotensin II antagonist saralasin in ovarian hyper stimulation syndrome in the rabbit

Gynecological Endocrinology ◽

10.3109/09513599709152539 ◽

1997 ◽

Vol 11 (4) ◽

pp. 231-236 ◽

Cited By ~ 11

Author(s):

Y. Şahin ◽

O. Kontaş ◽

I. I. Müderris ◽

M. Cankurtaran

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Ovarian Hyper Stimulation Syndrome ◽

Comparison of the Angiotensin II Antagonist UP269–6 with the Angiotensin Converting Enzyme Inhibitor Enalapril in Normotensive Volunteers Challenged with Angiotensin I

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199506000-00019 ◽

1995 ◽

Vol 25 (6) ◽

pp. 986-993 ◽

Cited By ~ 15

Author(s):

Nikolaos Inglessis ◽

Jürg Nussberger ◽

Michael Hagmann ◽

Odile Hiesse-Provost ◽

Jorge Insuasty ◽

...

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin I ◽

Clinical potential: angiotensin converting enzyme inhibitor or angiotensin II antagonist?

Journal of Hypertension ◽

10.1097/00004872-200106001-00009 ◽

2001 ◽

Vol 19 ◽

pp. S61-S67 ◽

Cited By ~ 7

Author(s):

Gordon T. Mclnnes

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin Ii Antagonist ◽

Clinical Potential

Faculty Opinions recommendation of Effects on insulin action of adding low-dose thiazide to angiotensin-converting enzyme inhibitor in essential hypertension.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717985483.793473970 ◽

2013 ◽

Author(s):

Bo Carlberg ◽

Mattias Brunström

Keyword(s):

Essential Hypertension ◽

Insulin Action ◽

Low Dose ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor

Association Between Angiotensinogen, Angiotensin II Receptor Genes, and Blood Pressure Response to an Angiotensin-Converting Enzyme Inhibitor

Circulation ◽

10.1161/circulationaha.106.642058 ◽

2007 ◽

Vol 115 (6) ◽

pp. 725-732 ◽

Cited By ~ 51

Author(s):

Xiaowen Su ◽

Liming Lee ◽

Xiaohui Li ◽

Jun Lv ◽

Yonghua Hu ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Blood Pressure Response ◽

Pressure Response ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitor

Correction: Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans

PLoS ONE ◽

10.1371/journal.pone.0251897 ◽

2021 ◽

Vol 16 (5) ◽

pp. e0251897

Author(s):

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Us Veterans

Fosenopril, an angiotensin-converting enzyme inhibitor, and propranolol: Comparative effects at rest and exercise on blood pressure, hormonal variables, and plasma potassium in essential hypertension

Cardiovascular Drugs and Therapy ◽

10.1007/bf01881529 ◽

1989 ◽

Vol 3 (1) ◽

pp. 57-62 ◽

Cited By ~ 5

Author(s):

Patrick A Sullivan ◽

Justine Cervenka ◽

Daniel T. O'Connor ◽

Mary Dineen

Keyword(s):

Blood Pressure ◽

Essential Hypertension ◽

Enzyme Inhibitor ◽

Plasma Potassium ◽

Converting Enzyme ◽

Rest And Exercise

MK-421: A new oral angiotensin converting enzyme inhibitor for essential hypertension

The American Journal of Cardiology ◽

10.1016/0002-9149(81)90954-1 ◽

1981 ◽

Vol 47 ◽

pp. 470 ◽

Cited By ~ 7

Author(s):

Roger K Ferguson ◽

Peter H. Vlasses ◽

Brian N. Swanson ◽

David J. Cooper ◽

Richard O. Davies ◽

...

Keyword(s):

Essential Hypertension ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor